Identification of innate immunity genes and pathways using a comparative genomics approach

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 19, 2008, Pages 7016-7021

  Alper, Scott ^a,c   Laws, Rebecca ^d   Lackford, Brad ^a   Boyd, Windy A ^b   Dunlap, Paul ^b   Freedman, Jonathan H ^b   Schwartz, David A ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DUKE UNIVERSITY   (United States)

Author keywords

Caenorhabditis elegans; Macrophage

Indexed keywords

ACY1 GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CAENORHABDITIS ELEGANS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; GENE; HOST RESISTANCE; IMMUNOREGULATION; INNATE IMMUNITY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TBC1 GENE; TUB2 GENE; ANIMAL; CHROMOSOME; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; GENOMICS; METABOLISM; METHODOLOGY; MUTATION; PROTEIN ANALYSIS; RNA INTERFERENCE; SEQUENCE HOMOLOGY;

CAENORHABDITIS ELEGANS; MURINAE; PSEUDOMONAS AERUGINOSA;

CAENORHABDITIS ELEGANS PROTEIN; HYBRID PROTEIN;

ANIMALS; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; CHROMOSOMES; GENE EXPRESSION REGULATION; GENOMICS; IMMUNITY, NATURAL; MICE; MUTATION; PROTEIN INTERACTION MAPPING; RECOMBINANT FUSION PROTEINS; RNA INTERFERENCE; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 44349138378     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0802405105     Document Type: Article

References (62)

1. Kaufmann SHE, Medzhitov, Gordon (2004) The Innate Immune Response to Infection (ASM, Washington, DC).
2. Chaudhuri N, Dower SK, Whyte MK, Sabroe I (2005) Toll-like receptors and chronic lung disease. Clin Sci (London) 109:125-133.
3. Cook DN, Pisetsky DS, Schwartz DA (2004) Toll-like receptors in the pathogenesis of human disease. Nat Immunol 5:975-979.
4. Takeda K, Akira S (2005) Toll-like receptors in innate immunity. Int Immunol 17:1-14.
5. Hoebe K, et al. (2006) TLR signaling pathways: Opportunities for activation and blockade in pursuit of therapy. Curr Pharm Des 12:4123-4134.
6. Hoffman ES, Smith RE, Renaud RC, Jr (2005) From the analyst's couch: TLR-targeted therapeutics. Nat Rev Drug Discov 4:879-880.
7. Ishii KJ, Uematsu S, Akira S (2006) "Toll" gates for future immunotherapy. Curr Pharm Des 12:4135-4142.
8. O'Neill LA (2003) Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases. Curr Opin Pharmacol 3:396-403.
9. Ward SG, O'Neill LA (2003) Spotlight on new anti-inflammatory drug targets in the immune system. Curr Opin Pharmacol 3:391-395.
10. Burch LH, et al. (2006) Transcriptional response to endotoxin reveals role for interferon γ in lung neutrophil recruitment. Am J Physiol Lung Cell Mol Physiol 291:L677-L682.
11. Calvano SE, et al. (2005) A network-based analysis of systemic inflammation in humans. Nature 437:1032-1037.
12. Cook DN, et al. (2004) Genetic regulation of endotoxin-induced airway disease. Genomics 83:961-969.
13. Doyle SL, O'Neill LA (2006) Toll-like receptors: From the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem Pharmacol 72:1102-1113.
14. Foley E, O'Farrell PH (2004) Functional dissection of an innate immune response by a genome-wide RNAi screen. PLoS Biol 2:E203.
15. Hoebe K, et al. (2006) Genetic analysis of innate immunity. Adv Immunol 91:175-227.
16. Jeyaseelan S, Chu HW, Young SK, Worthen GS (2004) Transcriptional profiling of lipopolysaccharide-induced acute lung injury. Infect Immun 72:7247-7256.
17. Lemaitre B (2004) The road to Toll. Nat Rev Immunol 4:521-527.
18. O'Neill LA (2004) TLRs: Professor Mechnikov, sit on your hat. Trends Immunol 25:687-693.
19. Yu SL, et al. (2004) Differential gene expression in gram-negative and gram-positive sepsis. Am J Respir Crit Care Med 169:1135-1143.
20. Alper S, McBride SJ, Lackford B, Freedman JH, Schwartz DA (2007) Specificity and complexity of the C. elegans innate immune response. Mol Cell Biol 27:5544-5553.
21. Mallo GV, et al. (2002) Inducible antibacterial defense system in C. elegans. Curr Biol 12:1209-1214.
22. Kamath RS, et al. (2003) Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 421:231-237.
23. Couillault C, et al. (2004) TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM. Nat Immunol 5:488-494.
24. Ewbank JJ (2006) Signaling in the immune response. WormBook, ed The C. elegans Research Community. Available at www.wormbook.org.
25. Kim DH, et al. (2002) A conserved p38 MAP kinase pathway in Caenorhabditis elegans innate immunity. Science 297:623-626.
26. Liberati NT, et al. (2004) Requirement for a conserved Toll/interleukin-1 resistance domain protein in the Caenorhabditis elegans immune response. Proc Natl Acad Sci USA 101:6593-6598.
27. Pujol N, et al. (2001) A reverse genetic analysis of components of the Toll signaling pathway in Caenorhabditis elegans. Curr Biol 11:809-821.
28. Li S, et al. (2004) A map of the interactome network of the metazoan C elegans. Science 303:540-543.
29. Giot L, et al. (2003) A protein interaction map of Drosophila melanogaster. Science 302:1727-1736.
30. Kakinuma T, Ichikawa H, Tsukada Y, Nakamura T, Toh BH (2004) Interaction between p230 and MACF1 is associated with transport of a glycosyl phosphatidyl inositolanchored protein from the Golgi to the cell periphery. Exp Cell Res 298:388-398.
31. Neufeld TP, Tang AH, Rubin GM (1998) A genetic screen to identify components of the sina signaling pathway in Drosophila eye development. Genetics 148:277-286.
32. Tang AH, Neufeld TP, Kwan E, Rubin GM (1997) PHYL acts to down-regulate TTK88, a transcriptional repressor of neuronal cell fates, by a SINA-dependent mechanism. Cell 90:459-467.
33. Polekhina G, et al. (2002) Siah ubiquitin ligase is structurally related to TRAF and modulates TNF-alpha signaling. Nat Struct Biol 9:68-75.
34. Carty M, et al. (2006) The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nat Immunol 7:1074-1081.
35. Ghebrehiwet B, Peerschke EI (2004) cC1q-R (calreticulin) and gC1q-R/p33: Ubiquitously expressed multi-ligand binding cellular proteins involved in inflammation and infection. Mol Immunol 41:173-183.
36. Akira S (2003) Mammalian Toll-like receptors. Curr Opin Immunol 15:5-11.
37. Takeda K, Akira S (2004) TLR signaling pathways. Semin Immunol 16:3-9.
38. Kurz CL, Shapira M, Chen K, Baillie DL, Tan MW (2007) Caenorhabditis elegans pgp-5 is involved in resistance to bacterial infection and heavy metal and its regulation requires TIR-1 and a p38 map kinase cascade. Biochem Biophys Res Comm 363:438-443.
39. Aronoff DM, Carstens JK, Chen GH, Toews GB, Peters-Golden M (2006) Short communication: Differences between macrophages and dendritic cells in the cyclic AMP-dependent regulation of lipopolysaccharide-induced cytokine and chemokine synthesis. J Interferon Cytokine Res 26:827-833.
40. Bailly S, Ferrua B, Fay M, Gougerot-Pocidalo MA (1990) Differential regulation of IL 6, IL 1 A, IL 1 beta and TNF alpha production in LPS-stimulated human monocytes: Role of cyclic AMP. Cytokine 2:205-210.
41. Dahle MK, Myhre AE, Aasen AO, Wang JE (2005) Effects of forskolin on Kupffer cell production of interleukin-10 and tumor necrosis factor alpha differ from those of endogenous adenylyl cyclase activators: Possible role for adenylyl cyclase 9. Infect Immun 73:7290-7296.
42. Martin CA, Dorf MA (1991) Differential regulation of Interleukin-6, macrophage inflammatory protein-1, and JE/MCP-1 cytokine expression in macrophage cell lines. Cell Immunol 135:245-258.
43. Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783-801.
44. Ben-Neriah Y (2002) Regulatory functions of ubiquitination in the immune system. Nat Immunol 3:20-26.
45. Scheidereit C (2006) IkappaB kinase complexes: Gateways to NF-kappaB activation and transcription. Oncogene 25:6685-6705.
46. van Laar T, van der Eb AJ, Terleth C (2001) Mif1: A missing link between the unfolded protein response pathway and ER-associated protein degradation? Curr Protein Pept Sci 2:169-190.
47. Coux O, Tanaka K, Goldberg AL (1996) Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 65:801-847.
48. Calzado MA, Bacher S, Schmitz ML (2007) NF-kappaB inhibitors for the treatment of inflammatory diseases and cancer. Curr Med Chem 14:367-376.
49. Elliott PJ, Zollner TM, Boehncke WH (2003) Proteasome inhibition: A new antiinflammatory strategy. J Mol Med 81:235-245.
50. Wang J, Maldonado MA (2006) The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases. Cell Mol Immunol 3:255-261.
51. Ralph P, Nakoinz I (1975) Phagocytosis and cytolysis by a macrophage tumour and its cloned cell line. Nature 257:393-394.
52. Fernandez-Botran R, Vťvička V (2001) Methods in Cell Immunology (CRC, Boca Raton, FL).
53. Sorensen DR, Leirdal M, Sioud M (2003) Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J Mol Biol 327:761-766.
54. Rahme LG, et al. (1995) Common virulence factors for bacterial pathogenicity in plants and animals. Science 268:1899-1902.
55. Mitchell DH, Stiles JW, Santelli J, Sanadi DR (1979) Synchronous growth and aging of Caenorhabditis elegans in the presence of fluorodeoxyuridine. J Gerontol 34:28-36.
56. Shapira M, et al. (2006) A conserved role for a GATA transcription factor in regulating epithelial innate immune responses. Proc Natl Acad Sci USA 103:14086-14091.
57. Voy BH, et al. (2006) Extracting gene networks for low-dose radiation using graph theoretical algorithms. PLoS Comput Biol 2:e89.
58. Kerr JR, et al. (2005) Single-nucleotide polymorphisms associated with symptomatic infection and differential human gene expression in healthy seropositive persons each implicate the cytoskeleton, integrin signaling, and oncosuppression in the pathogenesis of human parvovirus B19 infection. J Infect Dis 192:276-286.
59. Bouwmeester T, et al. (2004) A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. Nat Cell Biol 6:97-105.
60. -/- mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat Genet 36:969-977.
61. Smookler DS, et al. (2006) Tissue inhibitor of metalloproteinase 3 regulates TNF-dependent systemic inflammation. J Immunol 176:721-725.
62. Halaschek-Wiener J, et al. (2005) Analysis of long-lived C. elegans daf-2 mutants using serial analysis of gene expression. Genome Res 15:603-615.